Whether one is better than the other depends on your health and what your doctor advises
Differential expression analysis was performed using limma-voom, and significance was determined using two-sided statistical testing with multiple-comparison correction (adjusted P value)
Starting or restarting any peptide protocol requires a physician evaluation, appropriate lab work, and a clinical rationale
Similar results were obtained by examining the effect of CB2 receptor activation with the use of a specific agonist (GP1a) in the mouse model of skin wound healing
As for targeted therapy in cancer metabolism, gain of function mutations in isocitrate dehydrogenases (IDH1 and IDH2) result in the production of the oncometabolite 2-hydroxyglutarate (140, 141)
References to specific products, dosing schedules, or clinical protocols in this article are for informational and educational purposes only and do not constitute an endorsement of any specific treatment approach